These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1908080)
81. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Theodoulou A; Chepkin SC; Ye W; Fanshawe TR; Bullen C; Hartmann-Boyce J; Livingstone-Banks J; Hajizadeh A; Lindson N Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013308. PubMed ID: 37335995 [TBL] [Abstract][Full Text] [Related]
82. Evaluating the feasibility of pharmacist-facilitated tobacco cessation interventions in independent community pharmacies in rural Appalachia. Little MA; Porter KJ; Pebley K; Wiseman KP; Cohn W; Anderson RT; Krukowski RA J Am Pharm Assoc (2003); 2022; 62(6):1807-1815. PubMed ID: 35953377 [TBL] [Abstract][Full Text] [Related]
83. Strategies to improve smoking cessation rates in primary care. Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994 [TBL] [Abstract][Full Text] [Related]
84. Interventions for preventing weight gain after smoking cessation. Hartmann-Boyce J; Theodoulou A; Farley A; Hajek P; Lycett D; Jones LL; Kudlek L; Heath L; Hajizadeh A; Schenkels M; Aveyard P Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006219. PubMed ID: 34611902 [TBL] [Abstract][Full Text] [Related]
85. Screening for diabetic retinopathy with different levels of financial incentive in a randomized controlled trial. Lian JX; McGhee SM; So C; Kwong ASK; Sum R; Tsui WWS; Chao DVK; Chan JCH J Diabetes Investig; 2021 Sep; 12(9):1632-1641. PubMed ID: 33484625 [TBL] [Abstract][Full Text] [Related]
86. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Lindson N; Chepkin SC; Ye W; Fanshawe TR; Bullen C; Hartmann-Boyce J Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013308. PubMed ID: 30997928 [TBL] [Abstract][Full Text] [Related]
87. Evaluating the Impact of Eliminating Copayments for Tobacco Cessation Pharmacotherapy. Young-Wolff KC; Adams SR; Klebaner D; Adams AS; Campbell CI; Satre DD; Prochaska JJ Med Care; 2018 Nov; 56(11):912-918. PubMed ID: 30234768 [TBL] [Abstract][Full Text] [Related]
89. Healthcare financing systems for increasing the use of tobacco dependence treatment. van den Brand FA; Nagelhout GE; Reda AA; Winkens B; Evers SMAA; Kotz D; van Schayck OC Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004305. PubMed ID: 28898403 [TBL] [Abstract][Full Text] [Related]
90. Smoking cessation for free: outcomes of a study of three Romanian clinics. Trofor AC; Man MA; Marginean C; Dumitru F; Trofor L Open Med (Wars); 2016; 11(1):605-610. PubMed ID: 28352853 [TBL] [Abstract][Full Text] [Related]
91. Quitline Use and Outcomes among Callers with and without Mental Health Conditions: A 7-Month Follow-Up Evaluation in Three States. Vickerman KA; Schauer GL; Malarcher AM; Zhang L; Mowery P; Nash CM Biomed Res Int; 2015; 2015():817298. PubMed ID: 26273647 [TBL] [Abstract][Full Text] [Related]
92. Behavioral cessation treatment of waterpipe smoking: The first pilot randomized controlled trial. Asfar T; Al Ali R; Rastam S; Maziak W; Ward KD Addict Behav; 2014 Jun; 39(6):1066-74. PubMed ID: 24629480 [TBL] [Abstract][Full Text] [Related]
93. A randomized controlled trial of two different lengths of nicotine replacement therapy for smoking cessation. Abdullah AS; Hedley AJ; Chan SS; Lam TH Biomed Res Int; 2013; 2013():961751. PubMed ID: 24089693 [TBL] [Abstract][Full Text] [Related]
94. Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Ward KD; Asfar T; Al Ali R; Rastam S; Weg MW; Eissenberg T; Maziak W Addiction; 2013 Feb; 108(2):394-403. PubMed ID: 22882805 [TBL] [Abstract][Full Text] [Related]
95. A review of economic evaluations of tobacco control programs. Kahende JW; Loomis BR; Adhikari B; Marshall L Int J Environ Res Public Health; 2009 Jan; 6(1):51-68. PubMed ID: 19440269 [TBL] [Abstract][Full Text] [Related]
96. Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model. Abrams DB; Orleans CT; Niaura RS; Goldstein MG; Prochaska JO; Velicer W Ann Behav Med; 1996; 18(4):290-304. PubMed ID: 18425675 [TBL] [Abstract][Full Text] [Related]
97. Socioeconomic variations in nicotine dependence, self-efficacy, and intention to quit across four countries: findings from the International Tobacco Control (ITC) Four Country Survey. Siahpush M; McNeill A; Borland R; Fong GT Tob Control; 2006 Jun; 15 Suppl 3(Suppl 3):iii71-5. PubMed ID: 16754950 [TBL] [Abstract][Full Text] [Related]
98. Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment. Kaper J; Wagena EJ; van Schayck CP; Severens JL Pharmacoeconomics; 2006; 24(5):453-64. PubMed ID: 16706571 [TBL] [Abstract][Full Text] [Related]
99. Addressing tobacco in managed care: results of the 2002 survey. McPhillips-Tangum C; Bocchino C; Carreon R; Erceg C; Rehm B Prev Chronic Dis; 2004 Oct; 1(4):A04. PubMed ID: 15670435 [TBL] [Abstract][Full Text] [Related]
100. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Hughes JR; Shiffman S; Callas P; Zhang J Tob Control; 2003 Mar; 12(1):21-7. PubMed ID: 12612357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]